Deepa J. Arachchillage

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

Hannah Cohen, Beverley J. Hunt, Maria Efthymiou et al. · The Lancet Haematology · 2016 · 404 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations

Brijesh Patel, Deepa J. Arachchillage, Carole A. Ridge et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 305 citations · Full text

Medicine, Infectious Diseases, Radiology +16

Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting

Franziska Michalski, Luise Tittl, Saskia Middeldorp et al. · Thrombosis and Haemostasis · 2016 · 104 citations · Full text

Medicine, Obstetrics, Pharmacology +17

Diagnosis and management of non-criteria obstetric antiphospholipid syndrome

Samuel J. Machin, Ian Mackie, Hannah Cohen et al. · Thrombosis and Haemostasis · 2014 · 97 citations

Medicine, Maternal Health, Obstetrics +15

Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome

Deepa J. Arachchillage, Maria Efthymiou, Ian Mackie et al. · Journal of Thrombosis and Haemostasis · 2014 · 82 citations · Full text

Medicine, Hematology, Immunology +15